Overall ICVX gets a fundamental rating of 3 out of 10. We evaluated ICVX against 525 industry peers in the Biotechnology industry. ICVX has a great financial health rating, but its profitability evaluates not so good. ICVX has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

ICVX had negative earnings in the past year.
In the past year ICVX has reported a negative cash flow from operations.

1.2 Ratios

Looking at the Return On Assets, with a value of -38.48%, ICVX is in the better half of the industry, outperforming 62.67% of the companies in the same industry.
With a decent Return On Equity value of -41.61%, ICVX is doing good in the industry, outperforming 71.96% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-38.48%
ROE	-41.61%
ROIC	N/A

ROA(3y)-59.36%

ROA(5y)N/A

ROE(3y)-206.85%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ICVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ICVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ICVX has more shares outstanding than it did 1 year ago.
There is no outstanding debt for ICVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 22.57 indicates that ICVX is not in any danger for bankruptcy at the moment.
ICVX has a better Altman-Z score (22.57) than 92.74% of its industry peers.
There is no outstanding debt for ICVX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	22.57

ROIC/WACCN/A

WACC10.99%

2.3 Liquidity

A Current Ratio of 18.10 indicates that ICVX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 18.10, ICVX belongs to the best of the industry, outperforming 91.55% of the companies in the same industry.
ICVX has a Quick Ratio of 18.10. This indicates that ICVX is financially healthy and has no problem in meeting its short term obligations.
ICVX has a better Quick ratio (18.10) than 91.55% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	18.1
Quick Ratio	18.1

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ICVX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.83%.
Looking at the last year, ICVX shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.

EPS 1Y (TTM)-1.83%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20%

Revenue 1Y (TTM)-100%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

ICVX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.96% yearly.
Based on estimates for the next years, ICVX will show a very strong growth in Revenue. The Revenue will grow by 194.45% on average per year.

EPS Next Y5.52%

EPS Next 2Y3.44%

EPS Next 3Y-1.53%

EPS Next 5Y18.96%

Revenue Next Year-100%

Revenue Next 2Y-41.42%

Revenue Next 3Y3.57%

Revenue Next 5Y194.45%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ICVX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICVX. No positive earnings are expected for the next year.